Literature DB >> 8003506

Energetics of catalysis by ribonucleases: fate of the 2',3'-cyclic phosphodiester intermediate.

J E Thompson1, F D Venegas, R T Raines.   

Abstract

Ribonucleases catalyze the hydrolysis of the P-O5' bond in RNA. This reaction occurs in two steps: transphosphorylation of RNA to a 2',3'-cyclic phosphodiester intermediate and hydrolysis of this intermediate to a 3'-phosphomonoester. 31P NMR spectroscopy was used to monitor the accumulation of the 2',3'-cyclic phosphodiester intermediate during the transphosphorylation and hydrolysis reactions catalyzed by various ribonucleases and by small molecules. The intermediate was found to accumulate during catalysis by monomeric bovine pancreatic ribonuclease A (RNase A), a dimer and a trimer of RNase A, bovine seminal ribonuclease, RNase T1, barnase, and RNase 1. These enzymes, which are of widely disparate phylogenetic origin, released rather than hydrolyzed most of the intermediate formed transphosphorylation of RNA. In contrast, the intermediate did not accumulate during catalysis by hydroxide ion or imidazole buffer. In the presence of these small molecules, hydrolysis is faster than transphosphorylation. A trapping experiment was used to assess the throughput of the reaction catalyzed by RNase A. [5,6-3H]Uridylyl-(3'-->5')adenosine was incubated with RNase A in the presence of excess unlabeled uridine 2',3'-cyclic phosphodiester, which dilutes the specific radioactivity of any released cyclic intermediate. Only 0.1% of the RNA substrate was found to be both transphosphorylated and hydrolyzed without dissociating from the enzyme. These results suggest that ribonucleases have evolved primarily to catalyze RNA transphosphorylation and not RNA hydrolysis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8003506     DOI: 10.1021/bi00189a047

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  43 in total

1.  Binding patterns and kinetics of RNase a interaction with RNA.

Authors:  S Safarian; A A Moosavi-Movahedi
Journal:  J Protein Chem       Date:  2000-07

2.  Molecular dynamics simulation of bovine pancreatic ribonuclease A-CpA and transition state-like complexes.

Authors:  Elena Formoso; Jon M Matxain; Xabier Lopez; Darrin M York
Journal:  J Phys Chem B       Date:  2010-06-03       Impact factor: 2.991

Review 3.  The 2',3'-cAMP-adenosine pathway.

Authors:  Edwin K Jackson
Journal:  Am J Physiol Renal Physiol       Date:  2011-09-21

4.  Structure and activity of the Cas3 HD nuclease MJ0384, an effector enzyme of the CRISPR interference.

Authors:  Natalia Beloglazova; Pierre Petit; Robert Flick; Greg Brown; Alexei Savchenko; Alexander F Yakunin
Journal:  EMBO J       Date:  2011-10-18       Impact factor: 11.598

Review 5.  Bovine pancreatic ribonuclease: fifty years of the first enzymatic reaction mechanism.

Authors:  Claudi M Cuchillo; M Victòria Nogués; Ronald T Raines
Journal:  Biochemistry       Date:  2011-08-24       Impact factor: 3.162

6.  Pentavalent Organo-Vanadates as Transition State Analogues for Phosphoryl Transfer Reactions.

Authors:  June M Messmore; Ronald T Raines
Journal:  J Am Chem Soc       Date:  2000-10-18       Impact factor: 15.419

Review 7.  Probing enzyme phosphoester interactions by combining mutagenesis and chemical modification of phosphate ester oxygens.

Authors:  James T Stivers; Rajesh Nagarajan
Journal:  Chem Rev       Date:  2006-08       Impact factor: 60.622

8.  Biochemical characterization of arterivirus nonstructural protein 11 reveals the nidovirus-wide conservation of a replicative endoribonuclease.

Authors:  Danny D Nedialkova; Rachel Ulferts; Erwin van den Born; Chris Lauber; Alexander E Gorbalenya; John Ziebuhr; Eric J Snijder
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

9.  Ribonuclease-Activated Cancer Prodrug.

Authors:  Gregory A Ellis; Nicholas A McGrath; Michael J Palte; Ronald T Raines
Journal:  ACS Med Chem Lett       Date:  2012-02-28       Impact factor: 4.345

10.  2',3'-cAMP, 3'-AMP, and 2'-AMP inhibit human aortic and coronary vascular smooth muscle cell proliferation via A2B receptors.

Authors:  Edwin K Jackson; Jin Ren; Delbert G Gillespie
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-05-27       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.